Pharmacokinetic profiles in rats after intravenous, oral, or dermal administration of dapsone

Drug Metabolism and Disposition

Volumn 28, Issue 8, 2000, Pages 925-929

  Helton, D R ^a   Osborne, D W ^a   Pierson, S K ^a   Buonarati, M H ^a   Bethem, R A ^a  

^a QLT Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; DIETHYLENE GLYCOL MONOETHYL ETHER;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG UPTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; DAPSONE; INFUSIONS, INTRAVENOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA;

EID: 0033856079     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Dapsone in rheumatoid arthritis
2. Dapsone: Modes of action, toxicity and possible strategies for increasing patient tolerance
3. Dapsone toxicity: Some current perspectives
4. A review of therapeutic and hemolytic effects of dapsone
5. Experience de la disulone dans le traitement de l'acne nodulaire grave
6. Minimum inhibitory concentration of dapsone and other antibiotics for clinical isolates of propionibacterium acnes. J. Invest Dermatol 114:
7. Acne treatment with diaminodiphenylsulfone
8. Development and evaluation of an intracutaneous depot formulation of corticosteroids using transcutol as a cosolvent: In-vitro, ex-vivo and in- vivo rat studies. J
9. Topical formulation development of a novel thymidylate synthase inhibitor for the treatment of psoriasis
10. The pharmacokinetics of a dapsone after oral administration to healthy volunteers. Br. J
11. The absolute oral bioavailability of dapsone in dogs and humans
12. A comparison of dapsone with 13-cisretinoic acid in the treatment of nodular cystic acne
13. The protective effects of vitamin E on the haemolysis associated with dapsone treatment in patients with dermatitis herpetiformis
14. The treatment of acne vulgaris with dapsone
15. Pharmacoketinetic observations on dapsone in dermatitis herpetiformis
16. Noninvasive tests of CYP3A enzymes
17. Clinical pharmacokinetics of dapsone